iX Biopharma Ltd. (SGX:42C)
Singapore · Delayed Price · Currency is SGD 0.0610
+0.0160 (35.56%)
At close: Sep 29, 2025
iX Biopharma Market Cap
iX Biopharma has a market cap or net worth of 54.17 million as of September 29, 2025. Its market cap has increased by 95.84% in one year.
Market Cap
54.17M
Enterprise Value
59.20M
Revenue
7.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since July 22, 2015, iX Biopharma's market cap has decreased from 330.51M to 54.17M, a decrease of -83.61%. That is a compound annual growth rate of -16.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 54.17M | 145.28% |
| Dec 31, 2024 | 22.08M | -35.96% |
| Dec 28, 2023 | 34.48M | -65.12% |
| Dec 30, 2022 | 98.85M | -32.86% |
| Dec 31, 2021 | 147.23M | -17.14% |
| Dec 31, 2020 | 177.70M | 21.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DBS Group Holdings | 142.70B |
| Oversea-Chinese Banking Corporation | 73.00B |
| Singapore Telecommunications | 70.34B |
| United Overseas Bank | 56.99B |
| Singapore Technologies Engineering | 26.35B |
| Jardine Matheson Holdings | 23.36B |
| Singapore Airlines | 19.85B |
| Wilmar International | 17.79B |